Sherleen Adamson, M.D., Ph.D., Dabt
About Sherleen Adamson, M.D., Ph.D., Dabt
Sherleen Adamson, M.D., Ph.D., DABT, is a toxicologist at Procter & Gamble with extensive research experience in neurotoxicology, nanoparticle functionalities, and neurodegenerative disorders.
Current Role at Procter & Gamble
Sherleen Adamson, M.D., Ph.D., works as a Toxicologist at Procter & Gamble in Mason, Ohio. She has held this position since 2018. In this role, she applies her extensive expertise in toxicological sciences to ensure the safety and efficacy of the company's products.
Previous Experience at Purdue University
Before joining Procter & Gamble, Sherleen Adamson served as a Postdoctoral Research Associate at Purdue University from 2013 to 2018. Prior to that, she was a Graduate Research Assistant at Purdue University from 2008 to 2013, where she conducted significant research in Neurotoxicology.
Academic Background and Education
Sherleen Adamson earned her Doctor of Philosophy (Ph.D.) in Neurotoxicology from Purdue University, where she studied from 2008 to 2013. She also holds a Master's Degree in Occupational Health and Toxicology from Guangxi Medical University (2004-2007), and a Doctor of Medicine (M.D.) from the same institution (1999-2004). Her academic research focused on various aspects of toxicology and neurotoxicity.
Research Focus and Contributions
Sherleen Adamson's research examines the impact of choroid plexus and neurotoxicant exposure on adult neurogenesis and neurodegenerative disorders. She also investigates the roles of the blood-brain barrier and blood-cerebrospinal fluid barrier in regulating metal homeostasis and the transport of neurodegenerative-associated proteins and nanoparticles. In addition, her work explores the impact of nanoparticle-biocorona on nanoparticle functionalities, cellular response, and nano-drug delivery systems.
Early Career at Guangxi Medical University
Sherleen Adamson began her career at Guangxi Medical University, where she served as a Graduate Teaching and Research Assistant from 2004 to 2007. Her early work focused on Occupational Health and Toxicology, laying the foundation for her future contributions to the field of toxicology.